Anmeldung erfolgt in Kürze...
Details werden geladen...
AstraZeneca said to have explored Bristol Myers merger | Fortune
Bristol Myers Squibb, which has a $133 billion market capitalization, could provide AstraZeneca with a bigger foothold in the US market.
Ähnliche Seiten
AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger | AstraZeneca | The Guardian
https://www.theguardian.com/business/2026/aug/03/astrazeneca-talks-bristol-myers-squibb-merger-pharmaceuticals
AstraZeneca shares drop on reports of $570b mega-merger | The Canberra Times | Canberra, ACT
https://www.canberratimes.com.au/story/9323165/astrazeneca-shares-drop-on-reports-of-570b-mega-merger/
AstraZeneca share prices drop amid £300bn mega-merger talks with US rival Bristol Myers Squibb | The Independent
https://www.independent.co.uk/news/business/astrazeneca-share-price-bristol-myers-squibb-b3026324.html
AstraZeneca-Aktie: Spekulationen um Mega-Deal mit Bristol Myers Squibb
https://www.finanzen.net/nachricht/aktien/insiderinfos-astrazeneca-aktie-spekulationen-um-mega-deal-mit-bristol-myers-squibb-15842501
AstraZeneca-Aktie: Pharmariese prüfte wohl Übernahme von Bristol Myers Squibb | 03.08.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/astrazeneca-aktie-pharmariese-pruefte-wohl-uebernahme-von-bristol-myers-squibb-1036398468